BioSpace News Archive

SpendEdge has been monitoring the global castor oil market and the market is poised to experience spend growth of more than USD 200 million between 2019-2024 at a CAGR of over 3% during the forecast period.

Although quitting smoking during the 1st trimester of pregnancy reduces the risk of low birth weight, it isn’t enough to protect the unborn child from being born shorter and with smaller brain size, a new study from the University of Eastern Finland shows.

Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will present a company overview at the upcoming Cowen & Co. 40th Annual Health Care Conference on Wednesday, March 4, 2020, at 11:20 a.m. ET in Boston, MA.

CRANFORD, N.J. , Feb. 26, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will present at the Third Annual LD Micro Virtual Conference on Wednesday, March 4, 2020 at 11 AM ET . Event: Thir

Leaders from The Permanente Federation, The SCAN Foundation and California Health Care Foundation will present “Treating the Other 1%: Americans with Unmet Needs,” a panel on March 17, 2020 at the South by Southwest® Conference in Austin, Texas.

Feb. 26, 2020 13:00 UTC Seattle Genetics to Present at the Cowen 40 th Annual Healthcare Conference BOTHELL, Wash.--( BUSINESS WIRE )-- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the Cowen 40 th Annual Healthcare Conference on Tuesday, March 3, 2020 at 9:20 a.m. Eastern Time. The presentation will be webcast live and available for replay from Seattle Genetics’ website at www.seattlegenetics.com in the Investors section. About Sea

SAN DIEGO , Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today that it intends to offer (the “Offering”), subject to market and other considerations, $450,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the “Convertible Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities

Premier Inc. released an annual report on its national drug shortage programs, detailing key accomplishments and successful outcomes that have been achieved in collaboration with nearly 1,600 member hospitals.

Feb. 26, 2020 13:03 UTC LOS ANGELES--( BUSINESS WIRE )-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. The sNDA approval wa

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020, at 9:20 a.m. EST.